Litigation Details for DANG v. AMARIN CORPORATION PLC (D.N.J. 2021)
✉ Email this page to a colleague
DANG v. AMARIN CORPORATION PLC (D.N.J. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-10-21 |
| Court | District Court, D. New Jersey | Date Terminated | 2024-11-05 |
| Cause | 15:78m(a) Securities Exchange Act | Assigned To | Robert Kirsch |
| Jury Demand | Plaintiff | Referred To | Tonianne J. Bongiovanni |
| Patents | 8,293,728; 8,318,715; 8,357,677; 8,367,652; 8,377,920; 8,399,446; 8,415,335; 8,426,399; 8,431,560; 8,440,650; 8,501,225; 8,518,929; 8,524,698 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in DANG v. AMARIN CORPORATION PLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for DANG v. AMARIN CORPORATION PLC (D.N.J. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-10-21 | 1 | Complaint | the patent lawsuits, the Asserted Patents included 14 of the Company’s U.S. patents: 8,293,728 (the …were the ‘728 patent, the ‘715 patent, the ‘677 patent, the ‘652 patent, the ‘560 patent, and the ‘929…728 patent); 8,318,715 (the ‘715 patent); 8,357,677 (the ‘677 patent); 8,367,652 (the ‘652 patent); 8,377,920…446 patent); 8,415,335 (the ‘335 patent); 8,426,399 (the ‘399 patent); 8,440,650 (the ‘650 patent); 8,501,225…invalidate these patents. And these patents were heavily prosecuted through the US Patent Office. 1 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
